Pathogens and Immunity最新文献

筛选
英文 中文
A Pilot Single Cell Analysis of the Zebrafish Embryo Cellular Responses to Uropathogenic Escherichia coli Infection. 斑马鱼胚胎细胞对尿路致病性大肠杆菌感染反应的中试单细胞分析。
Pathogens and Immunity Pub Date : 2022-02-04 eCollection Date: 2022-01-01 DOI: 10.20411/pai.v7i1.479
Ashley Rawson, Vijay Saxena, Hongyu Gao, Jenaya Hooks, Xiaoling Xuei, Patrick McGuire, Takashi Hato, David S Hains, Ryan M Anderson, Andrew L Schwaderer
{"title":"A Pilot Single Cell Analysis of the Zebrafish Embryo Cellular Responses to Uropathogenic <i>Escherichia coli</i> Infection.","authors":"Ashley Rawson,&nbsp;Vijay Saxena,&nbsp;Hongyu Gao,&nbsp;Jenaya Hooks,&nbsp;Xiaoling Xuei,&nbsp;Patrick McGuire,&nbsp;Takashi Hato,&nbsp;David S Hains,&nbsp;Ryan M Anderson,&nbsp;Andrew L Schwaderer","doi":"10.20411/pai.v7i1.479","DOIUrl":"https://doi.org/10.20411/pai.v7i1.479","url":null,"abstract":"<p><strong>Background: </strong>Uropathogenic <i>Escherichia coli</i> (UPEC) infections are common and when they disseminate can be of high morbidity.</p><p><strong>Methods: </strong>We studied the effects of UPEC infection using single cell RNA sequencing (scRNAseq) in zebrafish. Bulk RNA sequencing has historically been used to evaluate gene expression patterns, but scRNAseq allows gene expression to be evaluated at the single cell level and is optimal for evaluating heterogeneity within cell types and rare cell types. Zebrafish cohorts were injected with either saline or UPEC, and scRNAseq and canonical pathway analyses were performed.</p><p><strong>Results: </strong>Canonical pathway analysis of scRNAseq data provided key information regarding innate immune pathways in the cells determined to be thymus cells, ionocytes, macrophages/monocytes, and pronephros cells. Pathways activated in thymus cells included interleukin 6 (IL-6) signaling and production of reactive oxygen species. Fc receptor-mediated phagocytosis was a leading canonical pathway in the pronephros and macrophages. Genes that were downregulated in UPEC vs saline exposed embryos involved the cellular response to the Gram-negative endotoxin lipopolysaccharide (LPS) and included Forkhead Box O1a <i>(Foxo1a)</i>, Tribbles Pseudokinase 3 (<i>Trib3)</i>, Arginase 2 (<i>Arg2)</i> and Polo Like Kinase 3 (<i>Plk3).</i></p><p><strong>Conclusions: </strong>Because 4-day post fertilization zebrafish embryos only have innate immune systems, the scRNAseq provides insights into pathways and genes that cell types utilize in the bacterial response. Based on our analysis, we have identified genes and pathways that might serve as genetic targets for treatment and further investigation in UPEC infections at the single cell level.</p>","PeriodicalId":36419,"journal":{"name":"Pathogens and Immunity","volume":" ","pages":"1-18"},"PeriodicalIF":0.0,"publicationDate":"2022-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843076/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39933708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SARS in Cars: Carbon Dioxide Levels Provide a Simple Means to Assess Ventilation in Motor Vehicles. 汽车中的SARS:二氧化碳水平提供了一种评估机动车辆通风的简单方法。
Pathogens and Immunity Pub Date : 2022-02-02 eCollection Date: 2022-01-01 DOI: 10.20411/pai.v7i1.493
Muhammed F Haq, Jennifer L Cadnum, Matthew Carlisle, Michelle T Hecker, Curtis J Donskey
{"title":"SARS in Cars: Carbon Dioxide Levels Provide a Simple Means to Assess Ventilation in Motor Vehicles.","authors":"Muhammed F Haq,&nbsp;Jennifer L Cadnum,&nbsp;Matthew Carlisle,&nbsp;Michelle T Hecker,&nbsp;Curtis J Donskey","doi":"10.20411/pai.v7i1.493","DOIUrl":"https://doi.org/10.20411/pai.v7i1.493","url":null,"abstract":"<p><strong>Background: </strong>Poorly ventilated enclosed spaces pose a risk for airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and other respiratory viruses. Limited information is available on ventilation in motor vehicles under differing driving conditions.</p><p><strong>Methods: </strong>We conducted carbon dioxide measurements to assess ventilation in motor vehicles under varying driving conditions with 2 to 3 vehicle occupants. During routine driving, carbon dioxide produced by the breathing of vehicle occupants was measured inside 5 cars and a van under a variety of driving conditions with or without the ventilation fan on and with windows open or closed. Carbon dioxide readings above 800 parts per million (ppm) were considered an indicator of suboptimal ventilation.</p><p><strong>Results: </strong>Carbon dioxide levels remained below 800 ppm in all vehicles if the ventilation fan was on and/or the windows were open while parked or during city or highway driving. With the ventilation system set on non-recirculation mode, carbon dioxide levels rose above 800 ppm in all vehicles when the fan was off and the windows were closed while parked and during city driving, and in 2 of the 6 vehicles during highway driving. With the ventilation system set on recirculation mode, carbon dioxide rose above 800 ppm within 10 minutes in all vehicles tested.</p><p><strong>Conclusion: </strong>Carbon dioxide measurements could provide a practical and rapid method to assess ventilation in motor vehicles. Simple measures such as opening windows, turning on the fan, and avoiding the recirculation mode greatly improve ventilation.</p>","PeriodicalId":36419,"journal":{"name":"Pathogens and Immunity","volume":" ","pages":"19-30"},"PeriodicalIF":0.0,"publicationDate":"2022-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843085/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39933709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
HIV-1 is Transported into the Central Nervous System by Trafficking Infected Cells. HIV-1通过运输感染细胞进入中枢神经系统。
Pathogens and Immunity Pub Date : 2022-01-01 DOI: 10.20411/pai.v7i2.524
Laura P Kincer, Gretja Schnell, Ronald Swanstrom, Melissa B Miller, Serena Spudich, Joseph J Eron, Richard W Price, Sarah B Joseph
{"title":"HIV-1 is Transported into the Central Nervous System by Trafficking Infected Cells.","authors":"Laura P Kincer,&nbsp;Gretja Schnell,&nbsp;Ronald Swanstrom,&nbsp;Melissa B Miller,&nbsp;Serena Spudich,&nbsp;Joseph J Eron,&nbsp;Richard W Price,&nbsp;Sarah B Joseph","doi":"10.20411/pai.v7i2.524","DOIUrl":"https://doi.org/10.20411/pai.v7i2.524","url":null,"abstract":"<p><strong>Background: </strong>In this work, we carried out a cross-sectional study examining HIV-1 and HCV free virus concentrations in blood and cerebrospinal fluid (CSF) to determine whether HIV-1 enters the central nervous system (CNS) passively as virus particles or in the context of migrating infected cells. If virions migrate freely across the blood-cerebrospinal fluid barrier (BCSFB) or the blood-brain barrier (BBB) then HCV and HIV-1 would be detectable in the CSF at proportions similar to that in the blood. Alternatively, virus entry as an infected cell would favor selective entry of HIV-1.</p><p><strong>Methods: </strong>We measured HIV-1 and HCV viral loads in the CSF and blood plasma of 4 co-infected participants who were not on antiviral regimens for either infection. We also generated HIV-1 <i>env</i> sequences and performed phylogenetic analyses to determine whether HIV-1 populations in the CSF of these participants were being maintained by local replication.</p><p><strong>Results: </strong>While CSF samples taken from all participants had detectable levels of HIV-1, HCV was not detectable in any of the CSF samples despite participants having HCV concentrations in their blood plasma, which exceeded that of HIV-1. Further, there was no evidence of compartmentalized HIV-1 replication in the CNS (Supplementary Figure 1). These results are consistent with a model where HIV-1 particles cross the BBB or the BCSFB within infected cells. In this scenario, we would expect HIV-1 to reach the CSF more readily because the blood contains a much greater number of HIV-infected cells than HCV-infected cells.</p><p><strong>Conclusions: </strong>HCV entry into the CSF is restricted, indicating that virions do not freely migrate across these barriers and supporting the concept that HIV-1 is transported across the BCSFB and/or BBB by the migration of HIV-infected cells as part of an inflammatory response or normal surveillance.</p>","PeriodicalId":36419,"journal":{"name":"Pathogens and Immunity","volume":"7 2","pages":"131-142"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973728/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9474112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Evaluation of Interventions to Improve Ventilation in Households to Reduce Risk for Transmission of Severe Acute Respiratory Syndrome Coronavirus 2. 改善家庭通风以降低冠状病毒传播风险的干预措施评价
Pathogens and Immunity Pub Date : 2022-01-01 DOI: 10.20411/pai.v7i2.553
Wilson Ha, Mitchell A Stiefel, Jeremy R Gries, Jennifer L Cadnum, Maria M Torres-Teran, Brigid M Wilson, Curtis J Donskey
{"title":"Evaluation of Interventions to Improve Ventilation in Households to Reduce Risk for Transmission of Severe Acute Respiratory Syndrome Coronavirus 2.","authors":"Wilson Ha,&nbsp;Mitchell A Stiefel,&nbsp;Jeremy R Gries,&nbsp;Jennifer L Cadnum,&nbsp;Maria M Torres-Teran,&nbsp;Brigid M Wilson,&nbsp;Curtis J Donskey","doi":"10.20411/pai.v7i2.553","DOIUrl":"https://doi.org/10.20411/pai.v7i2.553","url":null,"abstract":"<p><strong>Background: </strong>Inadequate ventilation may contribute to the high risk for household transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).</p><p><strong>Methods: </strong>We evaluated the effectiveness of several interventions recommended to improve ventilation in households. In 7 residential homes, carbon dioxide monitoring was conducted to assess ventilation in occupied open areas such as family rooms and in bedrooms and/or offices. Carbon dioxide levels above 800 parts per million (ppm) were considered an indicator of suboptimal ventilation for the number of people present. In 1 of the 7 homes, various interventions to improve ventilation or to filter air were assessed in a kitchen area by measuring clearance of aerosol particles produced using an aerosol-based spray system and carbon dioxide generated by cooking with a gas stove.</p><p><strong>Results: </strong>Carbon dioxide levels rose above 800 ppm in bedrooms and offices with 2 occupants when windows and doors were closed and in open areas during gatherings of 5 to 10 people; carbon dioxide levels decreased when windows or doors were opened. Clearance of carbon dioxide and aerosol particles significantly increased with interventions including running fans, operating portable air cleaners, and opening windows, particularly when there was a noticeable breeze or when a window fan was used to blow contaminated air outside.</p><p><strong>Conclusion: </strong>In households, several measures to improve ventilation or air filtration were effective in reducing carbon dioxide accumulation or enhancing clearance of carbon dioxide and aerosol particles. Studies are needed to determine if interventions to improve ventilation can reduce the risk for airborne transmission of SARS-CoV-2 in households.</p>","PeriodicalId":36419,"journal":{"name":"Pathogens and Immunity","volume":"7 2","pages":"120-130"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836208/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10551238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Immune Dysregulation in Acute SARS-CoV-2 Infection. 急性SARS-CoV-2感染中的免疫失调
Pathogens and Immunity Pub Date : 2022-01-01 DOI: 10.20411/pai.v7i2.537
Lauren Grimm, Chinyere Onyeukwu, Grace Kenny, Danielle M Parent, Jia Fu, Shaurya Dhingra, Emily Yang, James Moy, P J Utz, Russell Tracy, Alan Landay
{"title":"Immune Dysregulation in Acute SARS-CoV-2 Infection.","authors":"Lauren Grimm,&nbsp;Chinyere Onyeukwu,&nbsp;Grace Kenny,&nbsp;Danielle M Parent,&nbsp;Jia Fu,&nbsp;Shaurya Dhingra,&nbsp;Emily Yang,&nbsp;James Moy,&nbsp;P J Utz,&nbsp;Russell Tracy,&nbsp;Alan Landay","doi":"10.20411/pai.v7i2.537","DOIUrl":"https://doi.org/10.20411/pai.v7i2.537","url":null,"abstract":"<p><strong>Introduction: </strong>Neutralizing antibodies have been shown to develop rapidly following SARS-CoV-2 infection, specifically against spike (S) protein, where cytokine release and production is understood to drive the humoral immune response during acute infection. Thus, we evaluated the quantity and function of antibodies across disease severities and analyzed the associated inflammatory and coagulation pathways to identify acute markers that correlate with antibody response following infection.</p><p><strong>Methods: </strong>Blood samples were collected from patients at time of diagnostic SARS-CoV-2 PCR testing between March 2020-November 2020. Plasma samples were analyzed using the MesoScale Discovery (MSD) Platform using the COVID-19 Serology Kit and U-Plex 8 analyte multiplex plate to measure anti-alpha and beta coronavirus antibody concentration and ACE2 blocking function, as well as plasma cytokines.</p><p><strong>Results: </strong>A total of 230 (181 unique patients) samples were analyzed across the 5 COVID-19 disease severities. We found that antibody quantity directly correlated with functional ability to block virus binding to membrane-bound ACE2, where a lower SARS-CoV-2 anti-spike/anti-RBD response corresponded with a lower antibody blocking potential compared to higher antibody response (anti-S1 r = 0.884, <i>P</i> < 0.001; anti-RBD r = 0.75, <i>P</i> < 0.001). Across all the soluble proinflammatory markers we examined, ICAM, IL-1β, IL-4, IL-6, TNFα, and Syndecan showed a statistically significant positive correlation between cytokine or epithelial marker and antibody quantity regardless of COVID-19 disease severity. Analysis of autoantibodies against type 1 interferon was not shown to be statistically significant between disease severity groups.</p><p><strong>Conclusion: </strong>Previous studies have shown that proinflammatory markers, including IL-6, IL-8, IL-1β, and TNFα, are significant predictors of COVID-19 disease severity, regardless of demographics or comorbidities. Our study demonstrated that not only are these proinflammatory markers, as well as IL-4, ICAM, and Syndecan, correlative of disease severity, they are also correlative of antibody quantity and quality following SARS-CoV-2 exposure.</p>","PeriodicalId":36419,"journal":{"name":"Pathogens and Immunity","volume":"7 2","pages":"143-170"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973727/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9388591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Update on the Pathogenesis, Virulence, and Treatment of Candida auris. 耳念珠菌的发病机制、毒力和治疗进展。
Pathogens and Immunity Pub Date : 2022-01-01 DOI: 10.20411/pai.v7i2.535
Richard R Watkins, Rachael Gowen, Michail S Lionakis, Mahmoud Ghannoum
{"title":"Update on the Pathogenesis, Virulence, and Treatment of <i>Candida auris</i>.","authors":"Richard R Watkins,&nbsp;Rachael Gowen,&nbsp;Michail S Lionakis,&nbsp;Mahmoud Ghannoum","doi":"10.20411/pai.v7i2.535","DOIUrl":"https://doi.org/10.20411/pai.v7i2.535","url":null,"abstract":"<p><p><i>Candida auris</i> is an emerging, multidrug resistant fungal pathogen that causes considerable morbidity and mortality. First identified in Japan in 2009, it has since been reported in more than 40 countries. <i>C. auris</i> can persist for long periods on different environmental surfaces as well as the skin. Clinical isolates are typically resistant to commonly prescribed antifungal drugs. Increasingly recognized as a cause of infections and outbreaks in nosocomial settings, <i>C. auris</i> is difficult to identify using traditional microbiological methods. One of the main reasons for the ongoing spread of <i>C. auris</i> is the multitude of virulence factors it possesses and uses against its human host that enables fungal persistence on the skin surface. Yet, many of the virulence mechanismsare unknown or remain incompletely understood. In this review, we summarize the evolution of virulence of <i>C. auris</i>, offer recommendations for combating this important human pathogen, and suggest directions for further research.</p>","PeriodicalId":36419,"journal":{"name":"Pathogens and Immunity","volume":"7 2","pages":"46-65"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620957/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9182906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
Erratum to: Use of a MAIT-Activating Ligand, 5-OP-RU, as a Mucosal Adjuvant in a Murine Model of Vibrio cholerae O1 Vaccination. 使用mait激活配体5-OP-RU在小鼠霍乱弧菌O1疫苗模型中作为粘膜佐剂
Pathogens and Immunity Pub Date : 2022-01-01 DOI: 10.20411/pai.v7i1.541
Owen Jensen, Shubhanshi Trivedi, Jackson G Cacioppo, Kelin Li, Jeffrey Aubé, J Scott Hale, Edward T Ryan, Daniel T Leung
{"title":"Erratum to: Use of a MAIT-Activating Ligand, 5-OP-RU, as a Mucosal Adjuvant in a Murine Model of <i>Vibrio cholerae</i> O1 Vaccination.","authors":"Owen Jensen,&nbsp;Shubhanshi Trivedi,&nbsp;Jackson G Cacioppo,&nbsp;Kelin Li,&nbsp;Jeffrey Aubé,&nbsp;J Scott Hale,&nbsp;Edward T Ryan,&nbsp;Daniel T Leung","doi":"10.20411/pai.v7i1.541","DOIUrl":"https://doi.org/10.20411/pai.v7i1.541","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.20411/pai.v7i1.525.].</p>","PeriodicalId":36419,"journal":{"name":"Pathogens and Immunity","volume":"7 1","pages":"145-146"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487527/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10124538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differential CD4+ T-Cell Cytokine and Cytotoxic Responses Between Reactivation and Latent Phases of Herpes Zoster Infection. 带状疱疹感染再激活期和潜伏期CD4+ t细胞因子和细胞毒性的差异反应。
Pathogens and Immunity Pub Date : 2022-01-01 DOI: 10.20411/pai.v7i2.560
Wenjie Jin, Mike Fang, Ismail Sayin, Carson Smith, Jeffrey L Hunter, Brian Richardson, Jackelyn B Golden, Christopher Haley, Kenneth E Schmader, Michael R Betts, Stephen K Tyring, Cheryl M Cameron, Mark J Cameron, David H Canada
{"title":"Differential CD4+ T-Cell Cytokine and Cytotoxic Responses Between Reactivation and Latent Phases of Herpes Zoster Infection.","authors":"Wenjie Jin,&nbsp;Mike Fang,&nbsp;Ismail Sayin,&nbsp;Carson Smith,&nbsp;Jeffrey L Hunter,&nbsp;Brian Richardson,&nbsp;Jackelyn B Golden,&nbsp;Christopher Haley,&nbsp;Kenneth E Schmader,&nbsp;Michael R Betts,&nbsp;Stephen K Tyring,&nbsp;Cheryl M Cameron,&nbsp;Mark J Cameron,&nbsp;David H Canada","doi":"10.20411/pai.v7i2.560","DOIUrl":"https://doi.org/10.20411/pai.v7i2.560","url":null,"abstract":"Background: CD4+ T cells are a critical component of effective immune responses to varicella zoster virus (VZV), but their functional properties during the reactivation acute vs latent phase of infection remain poorly defined. Methods: Here we assessed the functional and transcriptomic properties of peripheral blood CD4+ T cells in persons with acute herpes zoster (HZ) compared to those with a prior history of HZ infection using multicolor flow cytometry and RNA sequencing. Results: We found significant differences between the polyfunctionality of VZV-specific total memory, effector memory, and central memory CD4+ T cells in acute vs prior HZ. VZV-specific CD4+ memory T-cell responses in acute HZ reactivation had higher frequencies of IFN-γ and IL-2 producing cells compared to those with prior HZ. In addition, cytotoxic markers were higher in VZV-specific CD4+ T cells than non-VZV-specific cells. Transcriptomic analysis of ex vivo total memory CD4+ T cells from these individuals showed differential regulation of T-cell survival and differentiation pathways, including TCR, cytotoxic T lymphocytes (CTL), T helper, inflammation, and MTOR signaling pathways. These gene signatures correlated with the frequency of IFN-γ and IL-2 producing cells responding to VZV. Conclusions: In summary, VZV-specific CD4+ T cells from acute HZ individuals had unique functional and transcriptomic features, and VZV-specific CD4+ T cells as a group had a higher expression of cytotoxic molecules including Perforin, Granzyme-B, and CD107a.","PeriodicalId":36419,"journal":{"name":"Pathogens and Immunity","volume":"7 2","pages":"171-188"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973729/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9525686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rapid Diagnosis of Recurrent Paucibacillary Tuberculosis. 复发性少杆菌结核的快速诊断。
Pathogens and Immunity Pub Date : 2022-01-01 DOI: 10.20411/pai.v7i2.565
Claudia Jafari, Ioana D Olaru, Franziska Daduna, Christoph Lange, Barbara Kalsdorf
{"title":"Rapid Diagnosis of Recurrent Paucibacillary Tuberculosis.","authors":"Claudia Jafari,&nbsp;Ioana D Olaru,&nbsp;Franziska Daduna,&nbsp;Christoph Lange,&nbsp;Barbara Kalsdorf","doi":"10.20411/pai.v7i2.565","DOIUrl":"https://doi.org/10.20411/pai.v7i2.565","url":null,"abstract":"<p><strong>Introduction: </strong>The rapid diagnosis of tuberculosis recurrence can be challenging due to persistently positive detection of <i>Mycobacterium tuberculosis</i>-specific DNA from sputum and bronchopulmonary samples in the absence of active disease.</p><p><strong>Methods: </strong>We compared the diagnostic accuracy of the detection of <i>M. tuberculosis</i>-specific DNA by either Xpert (January 2010-June 2018) or Xpert Ultra (July 2018-June 2020) and <i>M. tuberculosis</i>-specific ELISPOT in bronchoalveolar lavage (BAL) samples with <i>M. tuberculosis</i> culture results from sputum or bronchopulmonary samples in patients with suspected recurrence of pulmonary tuberculosis.</p><p><strong>Results: </strong>Among 44 individuals with previous tuberculosis and a presumptive diagnosis of recurrent pulmonary tuberculosis, 4/44 (9.1%) were diagnosed with recurrent tuberculosis by culture. DNA of <i>M. tuberculosis</i> was detected by Xpert in BAL fluid in 1/4 (25%) individuals with recurrent tuberculosis and in 2/40 (5%) cases with past tuberculosis without recurrence, while BAL-ELISPOT with a cut-off of >4,000 early secretory antigenic target-6-specific or culture filtrate protein-10-specific interferon-γ-producing lymphocytes per 1 million BAL-lymphocytes was positive in 4/4 (100%) individuals with recurrent tuberculosis and in 2/40 (5%) cases of past tuberculosis without recurrence.</p><p><strong>Conclusion: </strong><i>M. tuberculosis</i>-specific BAL-ELISPOT is more accurate than BAL-Xpert for the diagnosis of paucibacillary tuberculosis recurrence.</p>","PeriodicalId":36419,"journal":{"name":"Pathogens and Immunity","volume":"7 2","pages":"189-202"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189871/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9868976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is France Once Again Looking for a Scapegoat? 法国又要找替罪羊了吗?
Pathogens and Immunity Pub Date : 2021-12-29 eCollection Date: 2021-01-01 DOI: 10.20411/pai.v6i2.490
Michael M Lederman, Jeffrey S Flier, Peter Hale, Ashley T Haase, William Powderly, Peter Reiss, Guido Silvestri, Rafick P Sekaly, Mirko Paiardini, Drew Weissman, Daniel R Kuritzkes, Leonard H Calabrese, Peter Agre, Gustavo Reyes-Teran, Alan L Landay, Sharon Lewin, Douglas D Richman, Paul Volberding, Peter W Hunt, Mauro Schechter
{"title":"Is France Once Again Looking for a Scapegoat?","authors":"Michael M Lederman,&nbsp;Jeffrey S Flier,&nbsp;Peter Hale,&nbsp;Ashley T Haase,&nbsp;William Powderly,&nbsp;Peter Reiss,&nbsp;Guido Silvestri,&nbsp;Rafick P Sekaly,&nbsp;Mirko Paiardini,&nbsp;Drew Weissman,&nbsp;Daniel R Kuritzkes,&nbsp;Leonard H Calabrese,&nbsp;Peter Agre,&nbsp;Gustavo Reyes-Teran,&nbsp;Alan L Landay,&nbsp;Sharon Lewin,&nbsp;Douglas D Richman,&nbsp;Paul Volberding,&nbsp;Peter W Hunt,&nbsp;Mauro Schechter","doi":"10.20411/pai.v6i2.490","DOIUrl":"https://doi.org/10.20411/pai.v6i2.490","url":null,"abstract":"<p><p>On September 10, 2021, a special tribunal established by the French government launched an inquiry into the activities of former health minister Dr. Agnes Buzyn who was charged with \"endangering the lives of others\". It is surprising to learn of this accusation and inquiry into the actions of a public health official whose response to the epidemic was, to all appearances, exemplary.</p>","PeriodicalId":36419,"journal":{"name":"Pathogens and Immunity","volume":" ","pages":"149-152"},"PeriodicalIF":0.0,"publicationDate":"2021-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792773/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39573417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信